Rat study suggests Allergan's failed antidepressant rapastinel may work as opioid addiction treatment Endpoints NewsLast month, when Allergan's $AGN once-touted pipeline star rapastinel crashed and burned a slate of pivotal depression studies, it looked like the experimental ...